DSIP is not FDA-approved for the treatment of sleep disorders or any other medical condition
Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study
The supplement could come in the form of an amino acid such as N-acetyl cysteine (NAC) or another dietary ingredient
Okada M, Ortiz E, Corzo G, Possani LD
Notably, both diseases share key pathways such as the release of certain inflammatory mediators and oxidative stress, suggesting that therapeutic strategies targeting these common nodes may be beneficial for both conditions, offering a potential for unified treatment approaches
If weight loss is your goal, speak with one of our Registered Nurses about our GLP-1 Plans